liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Novel biomarker profiles to improve individual diagnosis and prognosis in patients with suspected inflammatory bowel disease: protocol for the Nordic inception cohort study (NORDTREAT)
Odense Univ Hosp, Denmark; Univ Hosp Southern Denmark, Denmark; Parker Inst, Denmark.
Odense Univ Hosp, Denmark; Univ Southern Denmark, Denmark; Odense Univ Hosp, Denmark.
Landspitali Natl Univ Hosp Iceland, Iceland.
Orebro Univ Hosp, Sweden.
Show others and affiliations
2024 (English)In: BMJ Open, E-ISSN 2044-6055, Vol. 14, no 5, article id e083144Article in journal (Refereed) Published
Abstract [en]

Introduction Inflammatory bowel disease (IBD), including ulcerative colitis and Crohn's disease, can be challenging to diagnose, and treatment outcomes are difficult to predict. In the NORDTREAT cohort study, a Nordic prospective multicentre study, we aim to identify novel molecular biomarkers of diagnostic value by assessing the diagnostic test accuracy (cross-sectionally), as well as the prognostic utility when used as prognostic markers in the long-term (cohort study). In the diagnostic test accuracy study, the primary outcome is a successful diagnosis using one or more novel index tests at baseline compared with the ECCO criteria as the reference standard. The composite outcome of the prognostic utility study is 'severe IBD' within 52 weeks from inclusion, defined as one or more of the following three events: IBD-related surgery, IBD-related hospitalisation or IBD-related death. Methods and analysis We aim to recruit 800 patients referred on suspicion of IBD to this longitudinal observational study, a collaboration between 11 inclusion sites in Denmark, Iceland, Norway and Sweden. Inclusion will occur from February 2022 until December 2023 with screening and baseline visits for all participants and three outcome visits at weeks 12, 26 and 52 after baseline for IBD-diagnosed patients. Biological material (blood, faeces, biopsies, urine and hair), clinical data and lifestyle information will be collected during these scheduled visits. Ethics and dissemination This study will explore novel biomarkers to improve diagnostic accuracy and prediction of disease progression, thereby improving medical therapy and the quality of life for patients with IBD. The study is approved by the Ethics Committee (DK: S-20200051, v1.4, 16.10.2021; IS: VSNb2021070006/03.01, NO: 193064; SE: DNR 2021-05090) and the Danish Data Protecting Agency (20/54594). Results will be disseminated through peer-reviewed journals, patient associations and presentations at international conferences.

Place, publisher, year, edition, pages
BMJ PUBLISHING GROUP , 2024. Vol. 14, no 5, article id e083144
Keywords [en]
Inflammatory bowel disease; Prognosis; Gastroenterology; Endoscopy; Adult gastroenterology
National Category
Clinical Medicine
Identifiers
URN: urn:nbn:se:liu:diva-207238DOI: 10.1136/bmjopen-2023-083144ISI: 001276395700057PubMedID: 38754881OAI: oai:DiVA.org:liu-207238DiVA, id: diva2:1895388
Note

Funding Agencies|NordForsk (30 000 000 SKR) via Vinnova [2019-01185 NORDTREAT]; Rannis (NordForsk) [199782-0611]; Research Council of Norway [2988039]; Innovation Fund Denmark [90569 NORDTREAT, 8114-00026B]; Region of Southern Denmark (Fri og Strategisk Forskning) [21/17578, 1084, (A1381)]; Knud and Edith Eriksen Memorial Fund [75 000 DKR, 62786-2022]; Odense University Hospital [A5031]; Parker Institute; Oak Foundation [OCAY-13-309]

Available from: 2024-09-05 Created: 2024-09-05 Last updated: 2025-04-18

Open Access in DiVA

fulltext(754 kB)96 downloads
File information
File name FULLTEXT01.pdfFile size 754 kBChecksum SHA-512
e4b1cc1ac47ce20bcc5f062f554595251ecce2db6e08e4e583a49e987894dfd5a266194a2b3231f6d12a115d18f8ef767dde83f5f3bdd42f6b95f2efe9bfc402
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Söderholm, Johan D
By organisation
Division of Surgery, Orthopedics and OncologyFaculty of Medicine and Health SciencesDepartment of Surgery in Linköping
In the same journal
BMJ Open
Clinical Medicine

Search outside of DiVA

GoogleGoogle Scholar
Total: 96 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 75 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf